Tuberkulosis Okular
DOI:
https://doi.org/10.56951/medicinus.v35i2.93Kata Kunci:
tuberkulosis, tuberkulosis okular, tuberkulosis uveitis, terapi antituberkulosis, COTSAbstrak
Tuberkulosis okular (ocular tuberculosis/OTB) adalah penyakit kronis yang disebabkan oleh infeksi M. tuberculosis pada mata dengan manifestasi yang beragam dan dapat menyebabkan kebutaan. Indonesia adalah negara nomor dua tertinggi di dunia dalam jumlah kasus tuberkulosis (TB) dan 11% di antaranya merupakan kasus TB ekstrapulmonar, termasuk OTB. Presentasi klinis tersering pada kasus OTB adalah uveitis posterior, namun dapat juga melibatkan semua jaringan pada mata. OTB memiliki prognosis yang baik bila penderita menjalani terapi antituberkulosis secara penuh, namun terdapat banyak tantangan dalam menegakkan diagnosis dan memulai terapi. Terdapat konsensus internasional terbaru dari kelompok kerja Collaborative Ocular Tuberculosis Study (COTS) yang dapat membantu klinisi dalam mengelola penyakit ini.
Unduhan
Referensi
World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.
World Health Organization. Tuberculosis profile: Indonesia. 2019 [cited 2021 Feb 9]. Available from: https://worldhealthorg. shinyapps.io/tb_profiles/ inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22ID%22
American Academy of Ophthalmology. Basic and Clinical Science Course, Section 09: Intraocular Inflammation and Uveitis. San Fransisco: American Academy of Ophthalmology; 2018. p.229-236.
Testi I, Agrawal R, Mehta S, et al. Ocular tuberculosis: Where are we today?. Indian J Ophthalmol. 2020;68(9):1808-17. DOI: https://doi.org/10.4103/ijo.IJO_1451_20
Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101(1):6-9. DOI: https://doi.org/10.1136/bjophthalmol-2016-309531
Agrawal R, Testi I, Rousselot A, et al. Insights into the molecular pathogenesis of ocular tuberculosis [published online ahead of print, 2020 Nov 12]. Tuberculosis (Edinb). 2020;126:102018. DOI: https://doi.org/10.1016/j.tube.2020.102018
Albert DM and Raven ML. Ocular Tuberculosis. Microbiol Spectr. 2016;4(6):1-36. DOI: https://doi.org/10.1128/microbiolspec.TNMI7-0001-2016
Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):14-24. DOI: https://doi.org/10.3109/09273948.2014.986582
Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-16. DOI: https://doi.org/10.1016/j.ajo.2005.03.057
Agrawal R, Agarwal A, Jabs DA, et al. Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop [published online ahead of print, 2019 Dec 10]. Ocul Immunol Inflamm. 2019;1-11.
M A, El-Asrar A, Abouammoh M, Al-Mezaine HS. Tuberculous uveitis. Middle East Afr J Ophthalmol. 2009;16(4):188-201.
Rowland K, Guthmann R, Jamieson B, Malloy D. Clinical inquiries. How should we manage a patient with a positive PPD and prior BCG vaccination? J Fam Pract. 2006;55(8):718-20.
Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. Ophthalmology. 2021;128(2):266-76. DOI: https://doi.org/10.1016/j.ophtha.2020.01.008
Menteri Kesehatan Republic Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia; 2019 [cited 2021 Feb 9]. Available from: http://yankes.kemkes.go.id/unduh/fileunduhan_1610422577_801904.pdf/43.
Jiang T, Zhang X, Zhou M, Jiang R, Chang Q. Prognosis of Ocular Tuberculosis Following Long-Term Antitubercular Therapy [published online ahead of print, 2021 Feb 1]. J Ocul Pharmacol Ther. 2021;10. DOI: https://doi.org/10.1089/jop.2020.0100
Unduhan
Terbitan
Bagian
Diterbitkan
Unduhan
Lisensi
Hak Cipta (c) 2022 Fabiola Supit
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
Cara Mengutip
